Regulatory News: STENTYS (Paris:STNT) (FR0010949404 — STNT), a French group specialized in medical technologies for interventional cardiology, today announced its quarterly revenues and consolidated cash position at September 30, 2019. Revenues for the third quarter and first 9 months of 2019 € thousands Q3 2019 Q3 2018 % change 9M 2019 9M 2018 1 % change Europe 2 930 1,164 -20% 3,771 3,318 +14% Rest of the world 403 1,105 -63% 2,625 2,590 +1% Total revenues 1,333 2,269 -41% 6,396 5,908 +8%...